Atara Biotherapeutics (ATRA) Change in Inventory (2022 - 2025)
Atara Biotherapeutics' (ATRA) quarterly Change in Inventory came in at -$10.7 million in Q1 2025, down 267.06% YoY from $6.4 million in Q1 2024, and down 6759.38% on a QoQ basis from $160000.0 in Q4 2024.
Atara Biotherapeutics (ATRA) Change in Inventory (2022 - 2025) Analysis & Trends
Atara Biotherapeutics (ATRA) has 4 years of Change in Inventory data on file, last reported at -$10.7 million in Q1 2025.
- Quarterly Change in Inventory fell 267.06% year-over-year to -$10.7 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$10.7 million (down 340.3% YoY) and the FY2025 annual result came in at -$10.7 million, down 340.3% from the prior year.
- Change in Inventory retreated to -$10.7 million in Q1 2025, from $160000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $6.4 million in Q1 2024 to a low of -$10.7 million in Q1 2025.
- A 4-year average of $348500.0 and a median of $2.1 million in 2022 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2023 — Change in Inventory soared 96.41% — and 2024, when it slumped 275.51%.
- Tracing ATRA's Change in Inventory over 4 years: stood at $1.6 million in 2022, then soared by 96.41% to $3.1 million in 2023, then slumped by 94.86% to $160000.0 in 2024, then plunged by 6759.38% to -$10.7 million in 2025.
- The last three Change in Inventory figures came in at -$10.7 million (Q1 2025), $160000.0 (Q4 2024), and -$4.8 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.00 Bn | 132.14 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 65.24 Bn | 60.06 Bn | 1.37 Bn | - |
| 4 | Moderna | 62.41 Bn | 57.27 Bn | 52.00 Mn | 132.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 47.15 Mn |
| 6 | Alnylam Pharmaceuticals | 31.18 Bn | 27.88 Bn | 992.69 Mn | -280,000.00 |
| 7 | BioNTech SE | 28.93 Bn | 10.54 Bn | 668.28 Mn | 135.26 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 12.97 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - | - |
| 10 | Atara Biotherapeutics | 141.99 Mn | 125.43 Mn | 439,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -10.66 Mn |
| Mar 31, 2025 | -10.66 Mn |
| Dec 31, 2024 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | -4.77 Mn |
| Sep 30, 2024 | -4.77 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 6.38 Mn |
| Mar 31, 2024 | 6.38 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Dec 31, 2023 | 3.12 Mn |
| Sep 30, 2023 | -1.27 Mn |
| Sep 30, 2023 | -1.27 Mn |
| Jun 30, 2023 | 2.52 Mn |
| Jun 30, 2023 | 2.52 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Mar 31, 2023 | 3.75 Mn |
| Dec 31, 2022 | 1.59 Mn |
| Dec 31, 2022 | 1.59 Mn |